Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial
B. Daan Westenbrink*, Marco Alings, Christopher B. Granger, John H. Alexander, Renato D. Lopes, Elaine M. Hylek, Laine Thomas, Daniel M. Wojdyla, Michael Hanna, Matyas Keltai, P. Gabriel Steg, Raffaele De Caterina, Lars Wallentin, Wiek H. van Gilst
Research output: Contribution to journal › Article › Academic › peer-review
60Citations
(Scopus)
365Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Anemia is associated with bleeding and mortality, but not stroke, in patients with atrial fibrillation: Insights from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial'. Together they form a unique fingerprint.